Cargando…

Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD

RATIONALE & OBJECTIVE: The Kidney Failure Risk Equation (KFRE) is widely used to predict the risk of kidney replacement therapy (KRT) initiation in chronic kidney disease (CKD) stages G3-G5. The new Grams calculator developed for advanced CKD (stage G4+) predicts KRT initiation, cardiovascular e...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanabalasingam, Susan J., Iliescu, Eduard A., Norman, Patrick A., Day, Andrew G., Akbari, Ayub, Hundemer, Gregory L., White, Christine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014437/
https://www.ncbi.nlm.nih.gov/pubmed/35445190
http://dx.doi.org/10.1016/j.xkme.2022.100440
_version_ 1784688197932941312
author Thanabalasingam, Susan J.
Iliescu, Eduard A.
Norman, Patrick A.
Day, Andrew G.
Akbari, Ayub
Hundemer, Gregory L.
White, Christine A.
author_facet Thanabalasingam, Susan J.
Iliescu, Eduard A.
Norman, Patrick A.
Day, Andrew G.
Akbari, Ayub
Hundemer, Gregory L.
White, Christine A.
author_sort Thanabalasingam, Susan J.
collection PubMed
description RATIONALE & OBJECTIVE: The Kidney Failure Risk Equation (KFRE) is widely used to predict the risk of kidney replacement therapy (KRT) initiation in chronic kidney disease (CKD) stages G3-G5. The new Grams calculator developed for advanced CKD (stage G4+) predicts KRT initiation, cardiovascular events, and death by uniquely incorporating the competing risk of death. We aimed to validate this tool in a stage G4+ cohort for death and KRT. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 442 patients with CKD stage G4+ (mean ± SD age, 73 ± 12 years; mean ± SD estimated glomerular filtration rate, 20 ± 6.2 mL/min/1.73 m(2)) who visited the multidisciplinary CKD clinic at Kingston Health Sciences Center in Ontario, Canada. OUTCOMES & ANALYTICAL APPROACH: Discrimination and calibration were examined for the outcome of death using the 2- and 4-year Grams scores. The 2- and 5-year KFRE and 2- and 4-year Grams scores were compared in terms of discrimination and calibration for KRT. RESULTS: There were 91, 161, and 206 death events and 90, 145, and 159 KRT events in our cohort at 2, 4, and 5 years, respectively. The Grams model demonstrated modest discrimination for death at 4 years (area under the curve [AUC] 0.70; 95% CI, 0.65-0.75) and performed worse at 2 years (AUC, 0.63; 95% CI, 0.57-0.70). It only overpredicted death by approximately 10% across most of the predicted range. Both models had similar discrimination for KRT at 2 years (KFRE AUC, 0.83; 95% CI, 0.78-0.88 and Grams AUC, 0.8; 95% CI, 0.76-0.87), 4 years (Grams AUC, 0.82; 95% CI, 0.77-0.86), and 5 years (KFRE AUC, 0.81; 95% CI, 0.76-0.85). There was excellent calibration for KRT using the 2-year KFRE and Grams values for predicted risk thresholds of ≤15% and using the 5-year KFRE and 4-year Grams values for predicted risk thresholds of ≤20%. At higher risk ranges, KFRE overpredicts and Grams underpredicts the KRT risk. LIMITATIONS: This is a single-center study with a primarily White cohort limited by smaller sample sizes at the higher ranges of the predicted risks, particularly for the Grams calculator. CONCLUSIONS: The Grams model provides moderately accurate death predictions, and consideration should be given to its incorporation into patient education and advanced care planning. Both the Grams and KFRE models remain clinically useful for determining KRT risks in advanced CKD.
format Online
Article
Text
id pubmed-9014437
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90144372022-04-19 Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD Thanabalasingam, Susan J. Iliescu, Eduard A. Norman, Patrick A. Day, Andrew G. Akbari, Ayub Hundemer, Gregory L. White, Christine A. Kidney Med Original Research RATIONALE & OBJECTIVE: The Kidney Failure Risk Equation (KFRE) is widely used to predict the risk of kidney replacement therapy (KRT) initiation in chronic kidney disease (CKD) stages G3-G5. The new Grams calculator developed for advanced CKD (stage G4+) predicts KRT initiation, cardiovascular events, and death by uniquely incorporating the competing risk of death. We aimed to validate this tool in a stage G4+ cohort for death and KRT. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 442 patients with CKD stage G4+ (mean ± SD age, 73 ± 12 years; mean ± SD estimated glomerular filtration rate, 20 ± 6.2 mL/min/1.73 m(2)) who visited the multidisciplinary CKD clinic at Kingston Health Sciences Center in Ontario, Canada. OUTCOMES & ANALYTICAL APPROACH: Discrimination and calibration were examined for the outcome of death using the 2- and 4-year Grams scores. The 2- and 5-year KFRE and 2- and 4-year Grams scores were compared in terms of discrimination and calibration for KRT. RESULTS: There were 91, 161, and 206 death events and 90, 145, and 159 KRT events in our cohort at 2, 4, and 5 years, respectively. The Grams model demonstrated modest discrimination for death at 4 years (area under the curve [AUC] 0.70; 95% CI, 0.65-0.75) and performed worse at 2 years (AUC, 0.63; 95% CI, 0.57-0.70). It only overpredicted death by approximately 10% across most of the predicted range. Both models had similar discrimination for KRT at 2 years (KFRE AUC, 0.83; 95% CI, 0.78-0.88 and Grams AUC, 0.8; 95% CI, 0.76-0.87), 4 years (Grams AUC, 0.82; 95% CI, 0.77-0.86), and 5 years (KFRE AUC, 0.81; 95% CI, 0.76-0.85). There was excellent calibration for KRT using the 2-year KFRE and Grams values for predicted risk thresholds of ≤15% and using the 5-year KFRE and 4-year Grams values for predicted risk thresholds of ≤20%. At higher risk ranges, KFRE overpredicts and Grams underpredicts the KRT risk. LIMITATIONS: This is a single-center study with a primarily White cohort limited by smaller sample sizes at the higher ranges of the predicted risks, particularly for the Grams calculator. CONCLUSIONS: The Grams model provides moderately accurate death predictions, and consideration should be given to its incorporation into patient education and advanced care planning. Both the Grams and KFRE models remain clinically useful for determining KRT risks in advanced CKD. Elsevier 2022-03-07 /pmc/articles/PMC9014437/ /pubmed/35445190 http://dx.doi.org/10.1016/j.xkme.2022.100440 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Thanabalasingam, Susan J.
Iliescu, Eduard A.
Norman, Patrick A.
Day, Andrew G.
Akbari, Ayub
Hundemer, Gregory L.
White, Christine A.
Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD
title Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD
title_full Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD
title_fullStr Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD
title_full_unstemmed Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD
title_short Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD
title_sort independent external validation and comparison of death and kidney replacement therapy prediction models in advanced ckd
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014437/
https://www.ncbi.nlm.nih.gov/pubmed/35445190
http://dx.doi.org/10.1016/j.xkme.2022.100440
work_keys_str_mv AT thanabalasingamsusanj independentexternalvalidationandcomparisonofdeathandkidneyreplacementtherapypredictionmodelsinadvancedckd
AT iliescueduarda independentexternalvalidationandcomparisonofdeathandkidneyreplacementtherapypredictionmodelsinadvancedckd
AT normanpatricka independentexternalvalidationandcomparisonofdeathandkidneyreplacementtherapypredictionmodelsinadvancedckd
AT dayandrewg independentexternalvalidationandcomparisonofdeathandkidneyreplacementtherapypredictionmodelsinadvancedckd
AT akbariayub independentexternalvalidationandcomparisonofdeathandkidneyreplacementtherapypredictionmodelsinadvancedckd
AT hundemergregoryl independentexternalvalidationandcomparisonofdeathandkidneyreplacementtherapypredictionmodelsinadvancedckd
AT whitechristinea independentexternalvalidationandcomparisonofdeathandkidneyreplacementtherapypredictionmodelsinadvancedckd